Major mergers and acquisitions in the chemical industry, with the transaction value reaching $12.7 billion!
Since the start of the year there has been no let-up in the pace of acquisitions or sales in the chemicals industry, despite the global economic climate. In March, the global chemicals industry saw two big mergers of more than $4bn in the space of a week, with a combined $12.7bn worth of deals.
Solis to buy Diversey for $4.6 billion
U.S. specialty chemicals maker Solenis announced on March 8 that it would buy Diversey in an all-cash deal of about $4.6 billion, which is expected to close in the second half of 2023.
Solis, headquartered in Wilmington, Delaware, is a specialty chemical manufacturer for water-intensive industries. It was acquired by Platinum Equity in 2021 and has 49 manufacturing facilities worldwide.
Diversey is a provider of hygiene, infection prevention and cleaning solutions headquartered in Fort Mill, South Carolina, USA.
Solis CEO John Panichella will lead the combined company after the transition and integration. "By combining these two complementary businesses to help customers solve core challenges such as water and energy management, working together on sustainability issues, we are committed to building a cleaner, safer world and reducing environmental impacts," Panichella said.
Apollo Fund to acquire Univale for $8.1 billion
On March 14, Univar Solutions, a U.S. distributor of specialty chemicals and ingredients, and Apollo Global Management announced that they had entered into a definitive merger agreement under which Apollo funds, managed by Apollo affiliates, will acquire Univar in an all-cash transaction valued at approximately $8.1 billion.
The agreement provides for Univale shareholders to receive $36.15 per share in cash. The transaction is expected to close in the second half of 2023. Uniwell Solutions will continue to operate under its original name and brand after the transaction.
As a distributor, Uniwell repackages, mixes, stores and ships chemicals for more than 100,000 customers. The company earned $545 million on sales of $11.5 billion in 2022. About two-thirds of those sales are in the United States.
2026-08-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Chemical transactions may rebound first
-
When SWIFT Goes On-Chain: A New 24/7 Order for Cross-Border Payments
-
SK Chemicals Partners with China’s Kelinle to Build Its Own Waste-Plastic Supply Network
-
Chemical Tanker Explodes Off Oman Coast, Maritime Security Risk Escalates Again
-
Continental Tires Out, Franchise Power In: Continental Group Spins Off French Retail Arm to ASC in Strategic Pivot
-
Agrochemical Markets at a Crossroads: Winter Stockpiling Begins Amid Cost Pressures and Fragmented Demand
-
Afidopyropen: The Silent Assassin of Sap-Sucking Pests—Promise, Pitfalls, and the Path to Sustainable Deployment
-
Jiangsu Fengshan Biochem Gears Up for Strategic Expansion in Selective Herbicide Intermediates and Active Ingredients
-
Eastern Shenghong Projects First-Half Profit of 5 Billion Yuan – A Collective Turnaround for the Four Major Private Refiners? Is the Chemical Sector Rebounding?
-
Tinci Materials Calls Off 2.65 Billion Yuan Project as Electrolyte Giant Shifts Strategy
Recommend Reading
-
Brazil Slams Chinese Butyl Acrylate with Anti-Dumping Probe—Trade Tensions Heat Up in Specialty Chemicals
-
Xampla and DIC to Introduce PFAS-Free Morro Coating to Asia
-
Asian Paints Dives Deeper into the Desert: Unveils Second UAE Plant to Dominate GCC Coatings Market
-
“Fake Fame” in a Forgotten Dock: Chinese Authorities Bust $100,000 Counterfeit Building Materials Ring
-
From Rust to Recharge: Novonix Ignites America’s Graphite Independence with Twin Mega-Plants in Chattanooga
-
Supply remains generally loose, the acrylonitrile market fluctuates within a range
-
Polyester Bottle Chip Spot Price Rises on the 14th
-
Insufficient Cost and Demand Support; PTA Prices to Weaken
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Supply Side Still Has Variables, Lithium Carbonate Fluctuates